Open-label Placebo in Manual Therapy
Launched by STUDIO OSTEOPATICO BUSTO ARSIZIO · Mar 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a placebo treatment in patients with chronic low back pain. A placebo is a treatment that looks like the real one but doesn’t contain any active medicine. The goal is to understand how this type of treatment might help people who have been dealing with low back pain for at least three months. The trial is currently recruiting participants between the ages of 65 and 74, and it is open to all genders.
To be eligible for this trial, you need to be an adult (18 years or older) with a diagnosis of chronic low back pain made by a doctor. However, certain conditions like infections, fractures, or previous spinal surgery might disqualify you from participating. If you join the trial, you can expect to receive either the placebo treatment or standard care and will be monitored for changes in your pain levels. This study aims to provide insights into how the mind might influence pain relief, which could help improve treatment options for people suffering from low back pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (+18 years) who complain of chronic non-specific low back pain for at least 3 months with or without pain exacerbations at the time of recruitment, will be included.
- • -Patients will need to have a diagnosis of low back pain made by a physician
- Exclusion Criteria:
- • pathologies such as ankylosing spondylitis, infections, fractures, tumors or metastases.
- • Pregnant women
- • patients with previous spinal surgery or undergoing cortisone therapy in the 6 months prior to the trial
- • diseases that may affect the interpretation of results such as fibromyalgia
- • patients currently being treated by other specialists or other manual therapists
About Studio Osteopatico Busto Arsizio
Studio Osteopatico Busto Arsizio is a leading clinical trial sponsor specializing in osteopathic treatments and research. Committed to advancing the understanding of osteopathy, the studio conducts rigorous clinical trials aimed at evaluating the efficacy and safety of innovative therapeutic approaches. With a focus on evidence-based practice, the team collaborates with healthcare professionals and researchers to ensure the highest standards of clinical integrity and patient care. Their dedication to enhancing patient outcomes is reflected in their comprehensive research methodologies and commitment to ethical practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saronno, Varese, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported